Abbott Finalizes St. Jude Medical Acquisition
Abbott Laboratories has completed its acquisition of St. Jude Medical, integrating the company and expanding its medical device offerings.
Abbott Laboratories has officially integrated St. Jude Medical into its operations, marking a significant expansion in the company's medical device portfolio.
The acquisition, initially announced previously, combines the strengths of both Abbott and St. Jude Medical, particularly in cardiovascular and neuromodulation technologies.
This integration is set to enhance Abbott's global presence in the healthcare sector, adding to its established lines in diagnostics, nutrition, and pharmaceuticals.
The combined entity aims to deliver innovative solutions and improve patient care worldwide through its broadened technological capabilities.